307 related articles for article (PubMed ID: 28364940)
1. Seizing market shaping opportunities for vaccine cold chain equipment.
Azimi T; Franzel L; Probst N
Vaccine; 2017 Apr; 35(17):2260-2264. PubMed ID: 28364940
[TBL] [Abstract][Full Text] [Related]
2. Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.
Lennon P; Atuhaire B; Yavari S; Sampath V; Mvundura M; Ramanathan N; Robertson J
Vaccine; 2017 Apr; 35(17):2198-2202. PubMed ID: 28364931
[TBL] [Abstract][Full Text] [Related]
3. Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.
Malhame M; Baker E; Gandhi G; Jones A; Kalpaxis P; Iqbal R; Momeni Y; Nguyen A
Vaccine X; 2019 Aug; 2():100033. PubMed ID: 31384748
[TBL] [Abstract][Full Text] [Related]
4. Innovations in cold chain equipment for immunization supply chains.
Robertson J; Franzel L; Maire D
Vaccine; 2017 Apr; 35(17):2252-2259. PubMed ID: 28364939
[TBL] [Abstract][Full Text] [Related]
5. A Tale of 2 Countries: Implementation of the Cold Chain Equipment Optimization Platform in Guinea and Kenya.
Stammer E; Teklemariam L; Barry A; Millimono R; Chweya A; Danfakha N; Golia C; Herrera E; Patykewich L; Prosser W; Alva S
Glob Health Sci Pract; 2022 Oct; 10(5):. PubMed ID: 36316144
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned in shaping vaccine markets in low-income countries: a review of the vaccine market segment supported by the GAVI Alliance.
Gilchrist SA; Nanni A
Health Policy Plan; 2013 Dec; 28(8):838-46. PubMed ID: 23174880
[TBL] [Abstract][Full Text] [Related]
7. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
8. Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review.
Eriksson P; Gessner BD; Jaillard P; Morgan C; Le Gargasson JB
Vaccine; 2017 Apr; 35(17):2155-2161. PubMed ID: 28364924
[TBL] [Abstract][Full Text] [Related]
9. Improving cold chain systems: Challenges and solutions.
Ashok A; Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2217-2223. PubMed ID: 27670076
[TBL] [Abstract][Full Text] [Related]
10. Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.
Prosser W; Sagar K; Seidel M; Alva S
BMC Health Serv Res; 2022 Oct; 22(1):1237. PubMed ID: 36207724
[TBL] [Abstract][Full Text] [Related]
11. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
12. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
13. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
14. Replacement costs of cold storage equipment for medical products of public healthcare establishments of European Union countries.
Raimundo AM; Oliveira AVM; Silva C
Health Policy; 2018 Dec; 122(12):1403-1411. PubMed ID: 30220551
[TBL] [Abstract][Full Text] [Related]
15. Equity and immunization supply chain in Madagascar.
van den Ent MMVX; Yameogo A; Ribaira E; Hanson CM; Ratoto R; Rasolomanana S; Foncha C; Gasse F
Vaccine; 2017 Apr; 35(17):2148-2154. PubMed ID: 28364923
[TBL] [Abstract][Full Text] [Related]
16. Deployment of vaccine cold chain equipment in resource-limited settings: lessons from the Gavi Cold Chain Optimization Platform in Cameroon.
Nkwain J; Zambou VM; Nchinjoh SC; Agbor VN; Adidja A; Mbanga C; Edwidge NN; Ndoula ST; Andreas AN; Diack D; Di Mattei P; Wiwa O; Diaby O; Saidu Y
Int Health; 2024 Feb; ():. PubMed ID: 38333954
[TBL] [Abstract][Full Text] [Related]
17. The origins of the vaccine cold chain and a glimpse of the future.
Lloyd J; Cheyne J
Vaccine; 2017 Apr; 35(17):2115-2120. PubMed ID: 28364918
[TBL] [Abstract][Full Text] [Related]
18. Transforming vaccines supply chains in Nigeria.
Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
[TBL] [Abstract][Full Text] [Related]
19. The impact of implementing a demand forecasting system into a low-income country's supply chain.
Mueller LE; Haidari LA; Wateska AR; Phillips RJ; Schmitz MM; Connor DL; Norman BA; Brown ST; Welling JS; Lee BY
Vaccine; 2016 Jul; 34(32):3663-9. PubMed ID: 27219341
[TBL] [Abstract][Full Text] [Related]
20. Transforming cold chain performance and management in lower-income countries.
Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2107-2109. PubMed ID: 28364916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
